Thus, we have documented that CYP4F2 and VKORC1 polymorphisms boost the proinflammatory plaque environment (observed indirectly through the presence of ischemic heart disease), increasing the risk of plaque development. The gene discussed is VKORC1; the disease is coronary artery disorder.